Cookson Peirce & Co’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Cookson Peirce & Co's TXG Position: Q3 2026 in Review
Cookson Peirce & Co reduced its 10x Genomics (TXG) stake by 15% in Q3 2026, selling an estimated $699K and leaving 68,359 shares worth $6.18M. The position accounts for 0.22% of the portfolio, ranked #73.
Cookson Peirce & Co first reported a position in TXG in Q1 2021 and has held it in 6 quarters since. 483 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Cookson Peirce & Co held 68,359 shares of 10x Genomics worth $6.18M as of Q3 2026.
- Cookson Peirce & Co sold 11,953 10x Genomics shares in Q3 2026, an estimated $699K.
- 10x Genomics made up 0.22% of Cookson Peirce & Co's portfolio in Q3 2026, its #73 holding.
- Cookson Peirce & Co first reported a position in 10x Genomics in Q1 2021 and has held it in 6 quarters since.
- 483 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.